Skip to main content

Table 1 Patient characteristics of all patients enrolled in this study

From: Genetic variability of the core protein in hepatitis C virus genotype 4 in Saudi Arabian patients and its implication on pegylated interferon and ribavirin therapy

Variable R NR P-value
Age (yrs.)    
Mean ± SD* 45.82 ± 14.67 49.19 ± 15.26 0.152c
Median (25th-75th) 48.00(35.50-57.00) 52.50(44.50-59.00) 0.095a
Sex §    
Male count (%) 21(37.5%) 22(37.3%) 0.862b
Female count (%) 35(62.5%) 37(62.7%)  
Weight ( kg) * 74.54 ± 28.01 76.04 ± 18.81 0.609c
Bil (mg/dL)* 10.54 ± 4.89 12.09 ±6.83 0.42c
ALT (IU/L)* 76.59 ±57.5 82.2 ± 76.2 0.424c
AST (IU/L)* 59.27 ± 43.37 53.63 ± 55.81 0.14c
ALP (IU/L)* 98.4 ± 67.8 116.13 ± 60.98 0.538c
AFP (ng/mL)* 8.22 ±17.12 7.76 ± 18.18.47 0.904c
HCV load log10 5.74(5.21-6.40) 5.88(5.15-6.48) 0.837a
Median (25th-75th)    
Stage §    
≤2 count (%) 24(77.4%) 21(63.6%) 0.227b
≥3 count (%) 7(22.6%) 12(36.4%)  
Grade §    
≥1 count (%) 8(25%) 8(22.2%) 0.788b
3 count (%) 24(75%) 28(77.8%)  
Genotypes §    
4a (%) 39(58%) 28(42%) 0.02b
4d (%) 17(35%) 31(65%)  
  1. Bil, Bilirubin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase, AFP, α-fetoprotein.
  2. *Values are expressed as Mean±SD, values are expressed as median (interquartile range), §count (%).
  3. a:Nonparametric test (Mann–Whitney U test), b:Chi-squared test, c:independent t-test.